Cerus (CERS) Cash from Financing Activities (2010 - 2026)

Cerus (CERS) reported Cash from Financing Activities of $1.2 million for Q1 2026, up 11.3% on a YoY basis from $1.1 million in Q1 2025, and up 215.62% sequentially from -$1.0 million in Q4 2025.

Cerus (CERS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Cerus (CERS) has 17 years of Cash from Financing Activities data on file, last reported at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 11.3% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $352000.0 (down 25.74% YoY), and the FY2025 full-year result was $231000.0, down 95.35% from the prior year.
  • Cash from Financing Activities advanced to $1.2 million in Q1 2026, from -$1.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.6 million in Q3 2023 to a low of -$1.4 million in Q2 2024.
  • A 5-year average of $1.3 million and a median of $746000.0 in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 601.29% in 2023 and sank 710.98% in 2024, its largest moves.
  • Tracing CERS's Cash from Financing Activities over 5 years: stood at $457000.0 in 2022, then surged by 158.86% to $1.2 million in 2023, then plunged by 36.94% to $746000.0 in 2024, then sank by 238.2% to -$1.0 million in 2025, then jumped by 215.62% to $1.2 million in 2026.
  • Business Quant data shows CERS's Cash from Financing Activities at $1.2 million in Q1 2026, -$1.0 million in Q4 2025, and $320000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 17.31 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -451.20 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -25.00 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 21.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -26.93 Mn
10 Cerus 600.87 Mn 520.44 Mn 27.89 Mn 1.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.19 Mn
Mar 31, 2026 1.19 Mn
Dec 31, 2025 -1.03 Mn
Dec 31, 2025 -1.03 Mn
Sep 30, 2025 320,000.00
Sep 30, 2025 320,000.00
Jun 30, 2025 -129,000.00
Jun 30, 2025 -129,000.00
Mar 31, 2025 1.07 Mn
Mar 31, 2025 1.07 Mn
Dec 31, 2024 746,000.00
Dec 31, 2024 746,000.00
Sep 30, 2024 60,000.00
Sep 30, 2024 60,000.00
Jun 30, 2024 -1.40 Mn
Jun 30, 2024 -1.40 Mn
Mar 31, 2024 5.56 Mn
Mar 31, 2024 5.56 Mn
Dec 31, 2023 1.18 Mn
Dec 31, 2023 1.18 Mn